PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments.

MLA

Dan Zhang, et al. “PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments.” PLoS ONE, vol. 12, no. 1, Jan. 2017, p. e0170453. EBSCOhost, https://doi.org/10.1371/journal.pone.0170453.

APA

Dan Zhang, Xiangying Xia, Xixi Wang, Peng Zhang, Weiliang Lu, Yamei Yu, Shi Deng, Hanshuo Yang, Hongxia Zhu, Ningzhi Xu, & Shufang Liang. (2017). PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments. PLoS ONE, 12(1), e0170453. https://doi.org/10.1371/journal.pone.0170453

Chicago

Dan Zhang, Xiangying Xia, Xixi Wang, Peng Zhang, Weiliang Lu, Yamei Yu, Shi Deng, et al. 2017. “PGRMC1 Is a Novel Potential Tumor Biomarker of Human Renal Cell Carcinoma Based on Quantitative Proteomic and Integrative Biological Assessments.” PLoS ONE 12 (1): e0170453. doi:10.1371/journal.pone.0170453.